Named in honor of former Project ALS board member and inspiration Tom Kirchhoff, the Tom Kirchhoff Family Post-Doctoral Fellowship at Project ALS is given to promising young scientists already making a difference in ALS research. This April, the fellowship has been awarded to Emily Lowry, PhD, at Columbia University. Dr. Lowry currently works within the Project ALS Pre-Clinical Core at Columbia University, alongside Drs. Hynek Wichterle and Serge Przedborski, to identify and screen for potential ALS therapies. Emily has also helped to develop a novel compound in-house that has shown promise in several ALS models.
Dr. Lowry succeeds Joseph Klim, PhD, the first recipient of the Kirchhoff Fellowship. Thanks to the Kirchhoffs, Dr. Klim, a researcher in the Harvard laboratory of Kevin Eggan, made developments in identifying new therapeutic targets for ALS, including neuroinflammation, and the ALS proteasome.
Motor neurons project out to the muscles in our limbs to drive muscle contraction, allowing us to speak, breathe, and move. These cells are housed